PTO Form 1553 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 10/31/2017) |
Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
85758707 |
LAW OFFICE ASSIGNED |
LAW OFFICE 109 |
EXTENSION OF USE |
NO |
MARK SECTION |
MARK |
http://uspto.report/TM/85758707/mark.png |
LITERAL ELEMENT |
LUPANETA PACK |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font style, size or color. |
OWNER SECTION |
NAME |
AbbVie Endocrine Inc. |
STREET |
Dept. V377, Bldg. AP34-2 |
CITY |
North Chicago |
STATE |
Illinois |
ZIP/POSTAL CODE |
60064 |
COUNTRY |
United States |
PHONE |
847-937-3386 |
FAX |
847-938-2623 |
EMAIL |
XXXX |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations, namely, a hormone modifying agent |
GOODS OR SERVICES |
KEEP ALL LISTED |
FIRST USE ANYWHERE DATE |
02/06/2014 |
FIRST USE IN COMMERCE DATE |
02/06/2014 |
SPECIMEN FILE NAME(S) |
\\TICRS\EXPORT16\IMAGEOUT 16\857\587\85758707\xml17 \SOU0002.JPG |
SPECIMEN DESCRIPTION |
Scanned product label |
REQUEST TO DIVIDE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES IN USE |
1 |
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] |
100 |
TOTAL AMOUNT |
100 |
SIGNATURE SECTION |
DECLARATION SIGNATURE |
/Cheryl A. Withycombe/ |
SIGNATORY'S NAME |
Cheryl A. Withycombe |
SIGNATORY'S POSITION |
Attorney of Record, IL Bar Member |
DATE SIGNED |
05/27/2014 |
SIGNATORY'S PHONE NUMBER |
847-937-3386 |
FILING INFORMATION |
SUBMIT DATE |
Tue May 27 16:37:37 EDT 2014 |
TEAS STAMP |
USPTO/SOU-XXX.XX.XX.XXX-2
0140527163737830899-85758
707-5001d18c76361e94c6458
c232a2fe4f83223380661c663
7ce4d62a54a9891fa7d-DA-39
98-20140527161440234889 |
PTO Form 1553 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 10/31/2017) |
Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: LUPANETA PACK(Standard Characters, see http://uspto.report/TM/85758707/mark.png)
SERIAL NUMBER: 85758707
The applicant, AbbVie Endocrine Inc., having an address of
Dept. V377, Bldg. AP34-2
North Chicago, Illinois 60064
United States
is submitting the following allegation of use information:
For International Class 005:
Current identification: Pharmaceutical preparations, namely, a hormone modifying agent
The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as
subsequently modified for this specific class.
The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 02/06/2014, and first used in commerce at least as early as
02/06/2014, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting
of a(n) Scanned product label.
Specimen File1
The applicant is not filing a Request to Divide with this Allegation of Use form.
A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.
Declaration
STATEMENTS: The signatory believes that: if the applicant is filing the amendment to allege use under 15 U.S.C. Section 1051(c) or a statement of use under 15 U.S.C. Section 1051(d), the applicant is
the owner of the trademark/service mark sought to be registered; the applicant or the applicant's related company or licensee is using the mark in commerce on or in connection with all the
goods/services in the application or notice of allowance, or as subsequently modified, and such use by the applicant's related company or licensee inures to the benefit of the applicant; that to the
best of the signatory's knowledge and belief, no other person has the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in
connection with the goods/services of such other person, to cause confusion or mistake, or to deceive; and the specimen(s) shows the mark as used on or in connection with the goods/services in
commerce.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and
that all statements made on information and belief are believed to be true.
Signature: /Cheryl A. Withycombe/ Date Signed: 05/27/2014
Signatory's Name: Cheryl A. Withycombe
Signatory's Position: Attorney of Record, IL Bar Member
Signatory's Phone: 847-937-3386
RAM Sale Number: 85758707
RAM Accounting Date: 05/28/2014
Serial Number: 85758707
Internet Transmission Date: Tue May 27 16:37:37 EDT 2014
TEAS Stamp: USPTO/SOU-XXX.XX.XX.XXX-2014052716373783
0899-85758707-5001d18c76361e94c6458c232a
2fe4f83223380661c6637ce4d62a54a9891fa7d-
DA-3998-20140527161440234889